MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 06.11.2025
Caladrius Biosciences P/CF 2011-2026 | CLBS
P/CF Jährlich Caladrius Biosciences
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.185 | -0.173 | -0.105 | -0.116 | -3.7 | -1.63 | -2.34 | -1.81 | -1.03 | -0.629 | -2.29 | -5.12 | -6.13 | -2 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.105 | -6.13 | -1.95 |
P/CF anderer Aktien in der Pharmaeinzelhändler
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Aquestive Therapeutics
AQST
|
-8.91 | $ 4.18 | 1.95 % | $ 447 M |  USA |
 |
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M |  Germany |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-10.3 | $ 9.84 | 2.61 % | $ 636 M | USA |
 |
BioNTech SE
BNTX
|
70.7 | $ 98.9 | -4.44 % | $ 27.2 B | Germany |
 |
AgeX Therapeutics
AGE
|
-0.0018 | - | -10.17 % | $ 12.2 K | USA |
 |
I-Mab
IMAB
|
-0.266 | - | - | $ 866 M |  China |
 |
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B | USA |
 |
Burford Capital Limited
BUR
|
11.6 | $ 5.12 | 4.07 % | $ 813 M |  Britain |
 |
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M | Britain |
 |
AlloVir
ALVR
|
-0.632 | - | 4.14 % | $ 49.1 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M |  France |
 |
Genfit SA
GNFT
|
1.68 K | - | 2.54 % | $ 160 B | France |
 |
Cerus Corporation
CERS
|
102 | $ 2.6 | 27.83 % | $ 496 M | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
20.2 | $ 22.13 | -1.43 % | $ 3.67 B | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | USA |
 |
Athira Pharma
ATHA
|
-0.0166 | - | - | $ 269 M | USA |
 |
Applied Molecular Transport
AMTI
|
-0.236 | - | - | $ 10.1 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
-0.224 | - | - | $ 7.46 M |  Israel |
 |
AstraZeneca PLC
AZN
|
13.6 | - | - | $ 96.9 B | Britain |
 |
Atreca
BCEL
|
-0.607 | - | -11.76 % | $ 5.79 M | USA |
 |
Berkeley Lights
BLI
|
-2.46 | - | -7.31 % | $ 87 M | USA |
 |
Calithera Biosciences
CALA
|
-14.5 | - | -10.95 % | $ 876 K | USA |
 |
Advaxis
ADXS
|
-0.0633 | - | -9.65 % | $ 45.9 M | USA |
 |
CymaBay Therapeutics
CBAY
|
-47.3 | - | - | $ 3.45 B | USA |
 |
ChemoCentryx
CCXI
|
-0.024 | - | - | $ 3.74 B | USA |
 |
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - |  Russia |
 |
Checkmate Pharmaceuticals
CMPI
|
-0.982 | - | - | $ 231 M | USA |
 |
Aeterna Zentaris
AEZS
|
-4.82 | - | 5.93 % | $ 314 M |  Canada |
 |
Brainstorm Cell Therapeutics
BCLI
|
-0.696 | - | -2.5 % | $ 5.88 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | USA |
 |
Cardiff Oncology
CRDF
|
-3.07 | $ 1.74 | 0.57 % | $ 116 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
-0.64 | - | - | $ 26.5 M | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
-8.18 | - | - | $ 2.18 B | USA |
 |
AIkido Pharma
AIKI
|
-1.17 | - | 1.93 % | $ 17.4 M | USA |
 |
Dynavax Technologies Corporation
DVAX
|
26 | - | - | $ 2.02 B | USA |
 |
Akouos
AKUS
|
-2.7 | - | 0.23 % | $ 488 M | USA |
 |
Allakos
ALLK
|
-0.976 | - | - | $ 28.6 M | USA |
 |
Editas Medicine
EDIT
|
-1.25 | $ 2.91 | -3.0 % | $ 258 M | USA |
 |
Edesa Biotech
EDSA
|
-1.24 | $ 17.98 | -1.61 % | $ 57.5 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-0.537 | $ 2.99 | -6.27 % | $ 4.92 M | Israel |
 |
Eiger BioPharmaceuticals
EIGR
|
-0.0418 | - | -9.21 % | $ 2.55 M | USA |
 |
Eloxx Pharmaceuticals
ELOX
|
-0.193 | - | -5.68 % | $ 8.28 M | USA |
 |
CureVac N.V.
CVAC
|
-4.82 | - | - | $ 867 M | Germany |
 |
Ampio Pharmaceuticals
AMPE
|
-0.0776 | - | -11.43 % | $ 502 K | USA |
 |
Applied Therapeutics
APLT
|
-9.8 | - | - | $ 8.42 M | USA |
 |
Evogene Ltd.
EVGN
|
-2.68 | $ 0.8 | 2.56 % | $ 27.9 M | Israel |
 |
Aptose Biosciences
APTO
|
-0.0645 | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
-0.159 | - | -39.0 % | $ 4.57 M | USA |